Injectafer denied as not medically necessary by Humana?

Humana's specific coverage criteria for injectafer are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied Injectafer for Medical Necessity

A medical-necessity denial means Humana reviewed the clinical documentation submitted with the prior authorization and concluded the information provided did not demonstrate that Injectafer (ferric carboxymaltose) meets the plan's criteria for covered inpatient or outpatient IV iron replacement. Common gaps include insufficient documentation of the underlying diagnosis, an incomplete prior-treatment history, or failure to address each of Humana's specific clinical criteria in the submitted paperwork.

This denial is very commonly overturned on appeal when complete documentation is assembled. Medical-necessity decisions are reviewable through both internal appeal and independent external review — the insurer's determination is not final.

## Federal Appeal Framework

ACA §2719 entitles you to a full internal appeal and then external review by an accredited IRO after exhausting internal remedies. ERISA §503 applies to employer-sponsored plans and mandates full-and-fair review, including access to the specific criteria and evidence the plan used. The external-review filing window is typically four months from the denial notice. If your condition creates urgent clinical need, invoke the expedited review pathway, which requires a decision within 72 hours.

## Concrete Appeal Steps

1. Request the denial letter and Humana's medical policy for IV iron therapy — you are entitled to the exact clinical criteria applied. 2. Identify which criterion was found unmet or which documentation was missing. 3. Ask your prescriber to prepare a targeted medical-necessity letter addressing each Humana criterion directly. 4. Submit your internal appeal with the complete documentation package. 5. If denied at the internal level, file for independent external review within the four-month window.

## Documentation to Gather

• Diagnosis confirmation: Physician notes, laboratory results, and any specialist consultation that establishes the diagnosis and its severity, current as of the request date.
• Prior-treatment history: A chronological list of oral iron agents or alternative treatments tried, with start/stop dates, doses given, and documented clinical outcomes or reasons for discontinuation.
• Clinical severity: Objective chart documentation of symptoms, functional limitations, or comorbidities that make oral supplementation inadequate.
• Prescriber medical-necessity letter: Explicitly maps the patient's clinical profile to each of Humana's published coverage criteria, referencing the FDA-approved Injectafer prescribing label and any applicable specialty guideline organization.

## Criteria-Mapping Structure

Obtain the FDA-approved Injectafer prescribing label and Humana's published medical/pharmacy coverage policy for IV ferric carboxymaltose. Create a table:

| Humana coverage criterion | Corresponding chart documentation | |---|---| | Confirmed diagnosis with documented severity | [Chart note date, objective findings] | | Failure or intolerance of oral iron | [Dates, agents, documented outcomes] | | Prescriber attestation of clinical necessity | [Prescriber letter, dated] | | Any additional plan-specific requirement | [Relevant chart fact] |

Every unanswered criterion in the original submission is a reversible gap. A complete, criterion-mapped appeal package is the highest-yield step before escalating to external review.